Quantitative Investment Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-19,023
Closed -$186K 436
2021
Q1
$186K Buy
+19,023
New +$157K 0.02% 461
2020
Q4
Sell
-97,067
Closed -$419K 489
2020
Q3
$419K Buy
+97,067
New +$693K 0.04% 279
2020
Q2
Sell
-13,148
Closed -$46K 557
2020
Q1
$46K Buy
+13,148
New +$61K 0.01% 477
2019
Q4
Sell
-39,428
Closed -$140K 662
2019
Q3
$140K Sell
39,428
-104,503
-73% -$405K 0.01% 561
2019
Q2
$574K Buy
+143,931
New +$834K 0.02% 502
2018
Q2
Sell
-111,500
Closed -$2.21M 773
2018
Q1
$2.21M Buy
+111,500
New +$1.93M 0.04% 431
2017
Q2
Sell
-236,000
Closed -$1.4M 738
2017
Q1
$1.4M Buy
+236,000
New +$1.13M 0.02% 522

Other funds holding DVAX

Quantitative Investment Management's DVAX Position: Q2 2021 in Review

Quantitative Investment Management sold out of Dynavax Technologies (DVAX) in Q2 2021, closing a stake of 19,023 shares — an estimated $186K sold.

Quantitative Investment Management first reported a position in DVAX in Q1 2017 and held it in 7 quarters. The position peaked at $2.21M in Q1 2018. 154 funds tracked by Wall St. Rank hold DVAX as of Q2 2021.

  • Quantitative Investment Management reported no remaining Dynavax Technologies position as of Q2 2021 after selling out during the quarter.
  • Quantitative Investment Management sold 19,023 Dynavax Technologies shares in Q2 2021, an estimated $186K.
  • Quantitative Investment Management first reported a position in Dynavax Technologies in Q1 2017 and held it in 7 quarters.
  • Quantitative Investment Management's Dynavax Technologies position peaked at $2.21M in Q1 2018.
  • 154 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2021.

Based on Quantitative Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.